VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
WRB
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
WRBW. R. Berkley Corporation
$71.01$26.4B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksWRBQuarterly Financials

W. R. Berkley Corporation (WRB) Quarterly Financials

120+ quarters historyFree accessUpdated daily

W. R. Berkley Corporation (WRB) quarterly income statement — complete revenue, gross profit & net income history

WRB Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue3.69B3.72B3.77B3.67B3.55B3.67B3.4B3.31B3.26B3.22B3.03B3B2.9B3.01B2.72B2.51B2.92B2.58B2.42B2.3B
Revenue Growth %3.98%1.4%10.82%10.77%8.92%13.85%12.2%10.62%12.5%6.89%11.24%19.22%-0.7%16.89%12.38%9.44%35.17%11.49%18.85%18.6%
Medical Costs & Claims1.94B2.95B3.08B2.99B2.76B2.74B2.68B2.62B2.48B2.42B2.4B2.31B2.31B2.27B2.3B2.11B2.02B1.99B1.92B1.81B
Medical Cost Ratio %52.49%79.42%81.77%81.58%77.87%74.75%78.91%78.93%76.05%75.13%79.34%77.17%79.7%75.37%84.42%84.08%69.27%77.06%79.36%78.96%
Gross Profit1.75B765.46M687.05M676.08M785.12M925.98M717.26M698.36M780.02M801.29M626.21M684.1M587.61M742.33M424.51M400.09M895.77M591.35M500.34M483.13M
Gross Margin %47.51%20.58%18.23%18.42%22.13%25.25%21.09%21.07%23.95%24.87%20.66%22.83%20.3%24.63%15.58%15.92%30.73%22.94%20.64%21.04%
Gross Profit Growth %123.23%-17.34%-4.21%-3.19%0.65%15.56%14.54%2.08%32.74%7.94%47.51%70.99%-34.4%25.53%-15.15%-17.19%99.97%-4.76%39.07%100.62%
Operating Expenses1.14B158.95M19.75M154.21M246.51M197.68M242.81M210.68M205.95M300.1M206.26M226.91M211.54M263.91M138.25M177.53M163.34M236.73M168.06M183.19M
OpEx / Revenue %30.81%4.27%0.52%4.2%6.95%5.39%7.14%6.36%6.32%9.32%6.81%7.57%7.31%8.76%5.07%7.06%5.6%9.18%6.93%7.98%
Depreciation & Amortization-15.47M0-9.07M-13.97M-9.79M-13.64M-11.93M-64.28M-80.78M-24.16M-3.61M-2.84M9.74M9.84M8.8M12.61M24.63M28.35M30.73M37.05M
Combined Ratio %83.3%83.69%82.29%85.78%84.82%80.14%86.05%85.28%82.37%84.44%86.14%84.74%87.01%84.13%89.49%91.14%74.88%86.25%86.29%86.94%
Operating Income616.1M606.51M667.3M521.86M538.61M728.3M474.45M487.67M574.07M501.2M419.95M457.18M376.07M478.42M286.26M222.56M732.43M354.62M332.28M299.94M
Operating Margin %16.7%16.31%17.71%14.22%15.18%19.86%13.95%14.72%17.63%15.56%13.86%15.26%12.99%15.87%10.51%8.86%25.12%13.75%13.71%13.06%
Operating Income Growth %14.39%-16.72%40.65%7.01%-6.18%45.31%12.98%6.67%52.65%4.76%46.7%105.42%-48.65%34.91%-13.85%-25.8%147.39%-11.21%60.98%184.44%
EBITDA600.63M601.57M658.24M507.89M528.82M714.66M462.52M423.39M493.29M477.04M416.34M454.35M385.81M488.26M295.06M235.17M757.06M382.97M363.01M336.99M
EBITDA Margin %16.28%16.18%17.47%13.84%14.91%19.49%13.6%12.78%15.15%14.81%13.74%15.17%13.33%16.2%10.83%9.36%25.97%14.85%14.97%14.68%
Interest Expense31.71M31.63M31.76M31.78M31.73M31.75M31.72M31.71M31.73M31.88M31.89M31.86M31.84M31.9M31.78M31.72M34.97M37.33M35.1M38.1M
Non-Operating Income-31.71M4.93M-12.17M-31.78M-31.73M-31.75M-31.72M-31.71M-31.73M-31.88M-31.89M-31.86M-31.84M-31.9M-31.78M-31.72M-34.97M-37.33M-35.1M-38.1M
Pretax Income616.1M571.96M648.11M521.86M538.61M728.3M474.45M487.67M574.07M501.2M419.95M457.18M376.07M478.42M286.26M222.56M732.43M354.62M332.28M299.94M
Pretax Margin %16.7%15.38%17.2%14.22%15.18%19.86%13.95%14.72%17.63%15.56%13.86%15.26%12.99%15.87%10.51%8.86%25.12%13.75%13.71%13.06%
Income Tax100.52M117.21M136.14M121.16M121.26M152.96M109.14M115.79M132.04M102.23M86.52M101.46M80.34M96.44M55.79M43.09M139.4M60.31M64.96M62.26M
Effective Tax Rate %16.32%20.49%21.01%23.22%22.51%21%23%23.74%23%20.4%20.6%22.19%21.36%20.16%19.49%19.36%19.03%17.01%19.55%20.76%
Net Income515.22M449.51M511.03M401.29M417.57M576.1M365.63M371.91M442.47M397.34M333.59M356.31M294.13M382.22M228.88M179.32M590.64M294.43M261.3M237.24M
Net Margin %13.97%12.09%13.56%10.93%11.77%15.71%10.75%11.22%13.59%12.33%11.01%11.89%10.16%12.68%8.4%7.14%20.26%11.42%10.78%10.33%
Net Income Growth %23.38%-21.97%39.77%7.9%-5.63%44.99%9.61%4.38%50.44%3.95%45.75%98.7%-50.2%29.82%-12.41%-24.41%157.33%-5.68%72.27%232.92%
EPS (Diluted)1.311.131.281.001.041.440.910.921.090.980.820.870.710.910.550.431.410.710.620.57
EPS Growth %25.96%-21.53%40.66%8.7%-4.59%46.94%10.98%5.75%53.52%7.69%49.09%102.33%-49.65%28.17%-11.29%-24.56%156.36%-4.05%72.22%235.29%
EPS (Basic)1.311.131.291.011.051.450.920.931.100.980.830.880.710.920.550.431.420.710.630.57
Diluted Shares Outstanding394.78M399.13M400.2M400.37M399.82M400.89M401.82M403.74M405.76M406.52M407.16M409.64M416.01M418.33M419.46M419.29M418.74M417.8M420.17M420.99M